SHORTS ON HIGH VOLUME

[Венцель]

посмотрел на FDA кэйс, вроде у них что то варится

надо разобраться поподробнее

а сколько они ожидают после апровал?($)

Дело тут непростое. Вкратце:
PDUFA date was 1/15 but FDA missed one the the 3-d party plants which will be making insulin for them. So fda has to inspect it and it has been 2 months, no one knows when that will happen. Originally management thought 2-4 weeks but did not happen. FDA not giving dates but seems very comfortable with the drug even before approval - they asked the company to extend the age of the upcoming juvenile drug trial from 8-14 years old to 4-14 years old. which I think is a huge sign. The inhaler they have now is good but they came up with a new design and decided not to bring the drug to market with the old ihnaler - they will wait till the new one is produced and approved. So really they will not start selling till q4 of this year. But if the drug is approved they are looking at 1-2 billion/year sales only in US. Speculation is - they have proposals from european partners waiting for an approval to step in. Analysts say that with approval and a partner stock can run to 30-50 right away. From $10 even the low end is 200% gain

[Alechko]

Дело тут непростое. Вкратце:
PDUFA date was 1/15 but FDA missed one the the 3-d party plants which will be making insulin for them. So fda has to inspect it and it has been 2 months, no one knows when that will happen. Originally management thought 2-4 weeks but did not happen. FDA not giving dates but seems very comfortable with the drug even before approval - they asked the company to extend the age of the upcoming juvenile drug trial from 8-14 years old to 4-14 years old. which I think is a huge sign. The inhaler they have now is good but they came up with a new design and decided not to bring the drug to market with the old ihnaler - they will wait till the new one is produced and approved. So really they will not start selling till q4 of this year. But if the drug is approved they are looking at 1-2 billion/year sales only in US. Speculation is - they have proposals from european partners waiting for an approval to step in. Analysts say that with approval and a partner stock can run to 30-50 right away. From $10 even the low end is 200% gain

i'll look at it tomorrow after the rulling on wamu's 4b case,

[Венцель]

i'll look at it tomorrow after the rulling on wamu's 4b case,

I hope you did not get burned too much on this one

[Alechko]

I hope you did not get burned too much on this one

i run free prefereds (mostly P's), bought one year and a half ago around
$1.5pps

i've converted 90% of commons to prefs a few day ago (see my previous posts) :34:

[Alechko]

WaMu reaches settlement with JPMorgan, FDIC
http://finance.yahoo.com/news/WaMu-r...eb376&ccode=mp

I would call it rather "proposed settlement"

Current Assets 6,933,444,337
Current Liabilities -8,313,698,526

Tax refund from deposits -????
30% of $2.8B 840,000,000
40.4% of $2.6B 1,050,000,000
Visa 50,000,000
Int Co Loans 179,000,000

New A/L 738,745,811

Preferreds 3,625,000,000

Min Preferred Payout 20%

[Alechko]

An attorney for the official committee of equity holders told the court that nobody told him about the settlement.:grum:
http://www.reuters.com/article/idUSN1215250120100312

[Alechko]

тик ток

обратный отсчет до wamu POR файлинга

[Alechko]

POR

[Alechko]

POR without a ballance sheet :grum:

500 pages, $1000 per page... Can I get a new attorney? lol ;)) those clowns are really funny

[Alechko]

Federal Judicial Center. Chapter 11 Reorganization: The Basics and the Judicial Role
http://www.youtube.com/watch?v=K0-jDdRQwpY